Skip to main content

Psychiatric and General Medical Comorbidity

  • Chapter
  • First Online:
Person Centered Psychiatry

Abstract

The observation that chronic disorders occur together frequently has become of increasing interest as it is now viewed as the norm and not the exception. Of concern is the increasing trend of comorbidity in younger populations especially in areas of socioeconomic deprivation and low income countries. There are reasons why comorbidity is of great importance not only in the context of diagnostic classification, aetiology and pathogenesis but also for models of health-care delivery, rationalisation of pharmacotherapy, patients’ self management and the complex simultaneous utilisation of health-care systems. There is a need, therefore, for a better understanding of the coexistence of various diseases in order to develop more effective and cost-effective interventions to improve health and social outcomes. Comorbidity in medicine is now viewed as one of the major challenges in the twenty-first century in terms of prevention and treatment. With comorbidity comes the increasing risk of mental health problems especially depression leading to potentially more complications and worse prognosis overall. It is already well established that those with severe mental illness suffer increased comorbid conditions and a reduced life expectancy due to predominantly comorbid cardiovascular problems. Fragmentation in the health-care system and the current single disease model only exacerbate the problem of effectively helping people experiencing comorbidities and especially comorbidities involving both mental and physical conditions. New ways of thinking are required to redesign healthcare systems for the development of effective early intervention and screening to treat coexisting conditions and enable clinicians to deliver more integrated person-centred care to improve health outcomes and quality of life for this population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bagdy G, Juhasz G. Biomarkers for personalised treatment in psychiatric diseases. Expert Opinion; Informa Healthcare. Med Dian. 2013;7(5):417–422.

    Google Scholar 

  2. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiolgy of multimorbidity and implications for healthcare, research, and medical education: a cross sectional study. Lancet. 2012;380(9836):37–43. doi:10.1016/S0140-6736(12)60240-2.

    Google Scholar 

  3. Citrome LL, et al. Risk of treatment/emergent diabetes mellitus in patients receiving antipsychotics. Ann Pharmacother. 2007;41:1593–603.

    Article  CAS  PubMed  Google Scholar 

  4. Cloninger CR, Salloum IM, Mezzich JE. The dynamic origins of positive health and wellbeing. Int J Person Centered Med. 2012;2(2):179–87.

    Google Scholar 

  5. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40.

    Article  CAS  PubMed  Google Scholar 

  6. Deakin B. et al. The physical health challenges in patients with severe mental illness: cardiovascular and metabolic risks. J Psychopharmacol. 2010;24(8).

    Google Scholar 

  7. De Hert M, et al. Physical Illness in patients with severe mental disorders II: Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10:52–77.

    Article  Google Scholar 

  8. Feinstein A. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23:455–68.

    Article  CAS  PubMed  Google Scholar 

  9. Fenton WS, Stover ES. Mood disorders: cardiovascular and diabetes comorbidity. Curr Opin Psychiatry. 2006;19(no4):421–7.

    Article  PubMed  Google Scholar 

  10. Flint J, Munafo M. Schizophrenia: genesis of a complex disease. Nature. 2014;511:412–3.

    Article  CAS  PubMed  Google Scholar 

  11. Goldberg D. The need for a special classification of mental disorders for general medical practice; towards ICD 11—primary care. Eur Psychiatry. 2011;26:53–6.

    Article  Google Scholar 

  12. Gregoor JG, van der Weide J, Mulder W, et al. Polymorphism of the LEP- and LEPR gene and obesity in patients using antipsychotic medication. J Clin Psychopharmacol. 2009;26:21–5.

    Article  Google Scholar 

  13. Grumbach K. Chronic illness, co-morbidities and the need for medical generalism. Ann Family Med. 2003;1:4–7.

    Article  Google Scholar 

  14. Harrison C, et al. Examining different measures of multimorbidity, using a large prospective cross-sectional study in Australian genral practice. BMJ Open. 2014;4:e004694. doi:10.1136/bmjopen-2013-004694.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Heald AL, Montejo A, Millar HL, Hert M, McCrae J, Correll C. Physical health in patients with schizophrenia: current knowledge and practical recommendations. Management of physical health in patients with schizophrenia: practical recommendations. J Eur Psychiatric Assoc. 2010;25(2):S1–S46.

    Google Scholar 

  16. Hutter N, Schnurr A, Baumeister H. Healthcare costs in patients with diabetes and comorbid mental disorders—a systematic review. Diabetiologia. 2010;53(12):2470–9.

    Article  CAS  Google Scholar 

  17. Katon WJ, et al. Multi-conditional collaborative care for chronic illnesses and depression. New Engl J. 2010;363:2611–20.

    Article  CAS  Google Scholar 

  18. Mezzich JE, Salloum IM, Cloninger CR, Salvador-Carulla L, Kirmayer LJ, Banzato CEM, Wallcraft J, Botbol M. Person-centred integrative diagnosis: conceptual bases and structural model. Can J Psychiatry (Revue Canadienne de Psychiatrie). 2010;55(11):701–8.

    Article  Google Scholar 

  19. Mezzich JE, Salloum IM. Comorbidity, positive health, and integration of services. In: Salloum IM, Mezzich JE, editors. Psychiatric diagnosis: challenges and prospects. Oxford, UK: Wiley-Blackwell; 2009.

    Google Scholar 

  20. Millar HL. The burden of multimorbidity: physical health in the severely mentally ill population. Die Psychiatrie. 2012.

    Google Scholar 

  21. Millar HL, Cimino L, van der Merwe AS. The dialogue on diabetes and depression African Nursing Training Programme: a collaborative training initiative to improve the recognition and management of diabetes and depression in Sub-Saharan Africa. In: Sartorius N, Maj M, Holt R, editors. Management of Comorbidity of Mental and Physical IIlness. Key Issues Mental Health. Basel, Karger 2015, 179, pp 148–156.

    Google Scholar 

  22. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases and decrements in health: results from the World Health Surveys. Lancet. 2007;370(9590):851–8.

    Article  PubMed  Google Scholar 

  23. Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund for Mental Health 2012.

    Google Scholar 

  24. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects. A comprehensive literature review. CNS Drugs. 2005;19:1–93.

    Article  CAS  PubMed  Google Scholar 

  25. Ngo VK, Rubenstein A, Ganju V, Kanellis P, Loza N, Rabadan C, Daar AS. Grand challenges: integrating mental health care into the non-communicable disease agenda. PLOS Med. 2013;10(5):e 1001443. doi:10.1371/journal.pmed.1001443.

    Google Scholar 

  26. Papakostas GI. The efficacy, tolerability and safety of contemporary antidepressants. J Clin Psychiatry. 2010;71:e03.

    Article  PubMed  Google Scholar 

  27. Patel V, et al. Effectiveness of an intervention led by lay health counsellors for depression and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial. Lancet. 2010;376(9758):2088–95.

    Article  Google Scholar 

  28. Prince M, Patel V, Shekhar S, Maj M, Maselko J, Philips MR, Rahman A, Maselko J. No heath without mental health. Lancet. 2007;370(9590):859–877. doi:10.1016/S0140-6736(07)61238-0.

    Google Scholar 

  29. Salisbury C. Multimorbidity: redesigning healthcare for people who use it. Lancet. 2012;. doi:10.1016/S0140-6736(12)60482-6.

    Google Scholar 

  30. Salloum IM, Mezzich JE, Cordoba SE. Conceptual and methodological considerations in comorbidity. In: Salloum IM, Mezzich JE, editors. Psychiatric diagnosis: challenges and prospects. Oxford, UK: Wiley-Blackwell; 2009.

    Google Scholar 

  31. Salloum IM, Abou-Saleh MT, Krasnov V. Comorbidity, psychiatric diagnosis and the person-centered integrative diagnostic model. Int J Person Centered Med. 2012;2(2):168–72.

    Google Scholar 

  32. Salloum IM, Mezzich JE. Outlining the bases of person-centred integrative diagnosis. J Eval Clin Practice. 2011;17(2):354–6.

    Article  Google Scholar 

  33. Salloum IM, Mezzich JE. Person-centered diagnosis. Int J Integr Care. 2010;10(Suppl):e027.

    PubMed  PubMed Central  Google Scholar 

  34. Starfield B. Thread and yarns: weaving the tapestry of co-morbidity. Ann Family Med. 2006;4:101–3.

    Article  Google Scholar 

  35. Taylor A, Price K, Gill T, et al. Multimorbidity—not just an older person’s issues: results from an Australian biomedical study. BMC Public Health. 2010;10:718.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Wang PS, et al. Dopamine antagonism and the development of breast cancer. Arch Gen Psychiatry. 2002;59:1147–54.

    Article  CAS  PubMed  Google Scholar 

  37. World Health Action Plan 2013–2020: Global Action Plan for the Prevention and Control of NCDs 2013-202.

    Google Scholar 

  38. World Health Organisation and Calouste Gulbenkian Foundation. Integrating the response to mental disorders and other chronic diseases in health care systems. Geneva: World Health Organisation; 2014.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Helen L. Millar MBChB, MRCPsych .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Millar, H.L., Salloum, I.M. (2016). Psychiatric and General Medical Comorbidity. In: Mezzich, J., Botbol, M., Christodoulou, G., Cloninger, C., Salloum, I. (eds) Person Centered Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-39724-5_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-39724-5_33

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-39722-1

  • Online ISBN: 978-3-319-39724-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics